Ajooni Biotech successfully develops Lumpy Skin Disease Medicine for Cattle

  • India Infoline News Service |
  • 08 Sep, 2022 |
  • 1:22 PM
Ajooni Biotech Ltd has successfully developed lumpy skin disease medicine for Cattle.

According to the regulatory filing, the company is constantly experimenting and working on research-based different health care solutions by a strong Research & Development team, working closely with leading research agencies, universities and independent scientists for product and process development.

"Its focus is to develop cost effective solutions to improve animal health, sustainable productivity of dairy and poultry farm, and thereby, the profitability of farmers", the company said on Thursday.

Further, the recent fast-spreading outbreak of lumpy skin disease (LSD) in cattle is estimated to have infected large number of animals particularly cows across India and over thousands of head of cattle have succumbed to the disease.

The Company has been working for the last few months to develop new medicines to control Lumpy Skin disease as a part of its regular research work and has been successful to produce a most effective formula at very reasonable cost by our expert team of Doctors and Scientists.

The animal starts improving with first few doses and fully recovered with in a week’s time. Ajooni has run very successful trails in Dairy Farms and results are very encouraging and really marvelous. The unique product is antipyretic, anti-inflammatory and antiallergic also. It overcomes the ill effects of Lumpy skin disease in addition to fever, lacrimation, hyper salivation and characteristic skin eruption.

In addition to this, Ajooni has an agreement with IFFCO KISAN, an organization committed to enriching farmer life and a sustainable ecosystem had started showing results with their combined efforts of marketing and supply of BIS Mark Cattle Feed for the state of Punjab, Haryana, Rajasthan, Himachal Pradesh, Jammu & Kashmir, and Western UP.

The Company has a long-term business plan to expand its facilities to produce Camel feed, Poultry feed, Aqua feed, Horse feed, and Sheep/Goat feed. The Company has set up under the project titled "Dairy Value Chain Development in Bundelkhand region of Uttar Pradesh" financially supported by National Rural Livelihood Mission (NRLM) & Uttar Pradesh State Rural Livelihood Mission (UP-SRLM) with NDDB Dairy Services (NDS) as technical Support Agency.

At around 1:22 PM, Ajooni Biotech was trading at Rs41.85 per equity share lower by 0.95% on the NSE.

For feedback and suggestions, write to us at

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required
ad IconAd Image

Most Read News

Article Image
  • 14 March, 2022 |
  • 7:03 AM

The US Federal committee's meeting will conclude on March 16, 2022.

Most Shared News

No Record Found